Sun Pharma trading at 783 with downfall by 3.85%
Sun Pharma trading at 783 with downfall by 3.85%.
May 31, 2016, 13:48 PM IST
Sun Pharma fourth quarter profit almost doubles but misses estimates
MUMBAI: India`s largest drugmaker Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts` estimates as weakness in emerging markets outweighed higher sales in India and the United States.
May 31, 2016, 12:11 PM IST
SPARC licenses Xelpros to Sun Pharma for US market
Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market.
Jun 09, 2015, 23:25 PM IST
